{"schema":"sb.node.v1","id":"sb:e/10edac331b32abeba767b45b","kind":"entity","label":{"text":"drug evaluation","locale":"en"},"identity":{"anchor":"label:en:drug evaluation","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-08T23:32:17.032179+00:00","snapshot":"deploy 5d87c360c5a522bd9c2b03f9e5746b635e3cba52"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":117,"separatePublishers":13,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"provisional","reason":"entity graph provenance 'observed'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-14","to":"2026-10-07","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.333: about 67% of mentions carry no typed assertion"]}},"dimensions":{"domains":["biotech_pharma","pharma-regulatory"],"activeDays":40,"assertions":{"regulatory-approval":35,"meeting-visit":2,"award":1,"utterance":1}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/e15f9f8e684dd3d7285fd3c8","kind":"observation","label":"FDA Drug News · 2026-06-26 · Center for Drug Evaluation and Research and the Office of the Chief Scientist Cosmetic Agreement","url":"http://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/center-drug-evaluation-and-research-and-office-chief-scientist-cosmetic-agreement"},{"id":"sb:o/4b9772cb5d97d55330a11fe1","kind":"observation","label":"FDA Drug News · 2026-06-13 · [APPROVAL] Real-World Evidence Submissions to the Center for Drug Evaluation and Research","url":"http://www.fda.gov/science-research/real-world-evidence/real-world-evidence-submissions-center-drug-evaluation-and-research"},{"id":"sb:o/0bfc863660eefb44953ba9e1","kind":"observation","label":"FDA Drug News · 2026-06-10 · About HIV and the Center for Drug Evaluation and Research's role","url":"http://www.fda.gov/drugs/drug-safety-and-availability/about-hiv-and-center-drug-evaluation-and-researchs-role"},{"id":"sb:o/3d039dfcbd55b0c8ceb29589","kind":"observation","label":"FDA Drug News · 2026-05-04 · Center for Drug Evaluation and Research Organization Chart","url":"http://www.fda.gov/about-fda/fda-organization-charts/center-drug-evaluation-and-research-organization-chart"},{"id":"sb:o/717d737a22f661dbf7a93f38","kind":"observation","label":"FDA Drug News · 2026-10-07 · [APPROVAL] The Platinum Healthcare LLC - 735147 - 10/01/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/platinum-healthcare-llc-735147-10012026"},{"id":"sb:o/cc83974bd16d85c672228c5c","kind":"observation","label":"FDA · 2026-10-07 · Walmart, Inc. - 736557 - 10/01/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walmart-inc-736557-10012026"},{"id":"sb:o/84f15c26c77f52522c6815e7","kind":"observation","label":"FDA · 2026-10-07 · TCI Co., Ltd BioCosme PABP BRANCH - 736888 - 09/02/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tci-co-ltd-biocosme-pabp-branch-736888-09022026"},{"id":"sb:o/355f98848396fbafb045bbb6","kind":"observation","label":"FDA · 2026-10-07 · Pine Pharmaceuticals, LLC - 728537 - 08/07/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pine-pharmaceuticals-llc-728537-08072026"},{"id":"sb:o/33b360cbcb43376424f6c3ad","kind":"observation","label":"FDA · 2026-10-07 · Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing","url":"http://www.fda.gov/regulatory-information/search-fda-guidance-documents/pharmacokinetics-patients-impaired-hepatic-function-study-design-data-analysis-and-impact-dosing"},{"id":"sb:o/01a40a388445cd2dcedb05d9","kind":"observation","label":"FDA · 2026-10-07 · Online Generic Medicine/www.onlinegenericmedicine.com - 737806 - 09/23/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/online-generic-medicinewwwonlinegenericmedicinecom-737806-09232026"}],"cursor":"c1.eyJpZCI6InNiOmUvMTBlZGFjMzMxYjMyYWJlYmE3NjdiNDViIiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTA4VDIzOjMyOjE3LjAzMjE3OSswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with fda (108 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c75706f89acad3da06a2353e"},{"kind":"relation","label":"co-mentioned with cder (76 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c5b704ae13afd874d312c538"},{"kind":"relation","label":"co-mentioned with drug administration (69 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c254ba73c2b7806edd1e2c44"},{"kind":"relation","label":"co-mentioned with united states (44 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/778fc5232e616fd221f8ee26"},{"kind":"relation","label":"co-mentioned with u.s. food (39 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/caf079c1199707a75a0bd417"},{"kind":"relation","label":"co-mentioned with drug development (38 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/81bf89d1fe802e49b213061d"},{"kind":"relation","label":"co-mentioned with public health (37 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/7e11deb85bd1bb6113238c74"},{"kind":"relation","label":"co-mentioned with federal food (34 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ba76cd03b3c0af1e54721149"},{"kind":"relation","label":"co-mentioned with cosmetic act (33 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/98e8ec7d9ff8353f4ad03ce8"},{"kind":"relation","label":"co-mentioned with fd&c act (31 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ccf9fb95389505cee46bdd96"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/10edac331b32abeba767b45b","mcp":"traverse {\"id\":\"sb:e/10edac331b32abeba767b45b\"}","page":"/entity/drug-evaluation/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/10edac331b32abeba767b45b\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/10edac331b32abeba767b45b\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/10edac331b32abeba767b45b\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/10edac331b32abeba767b45b\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}